THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

E-mails suggest Pfizer tried to suppress study on drug

Suits say company misled on Neurontin

Pfizer Inc. promoted the positive findings of a small Neurontin study. Pfizer Inc. promoted the positive findings of a small Neurontin study. (MARK LENNIHAN/ASSOCIATED PRESS/FILE)
By Liz Kowalczyk
Globe Staff / October 8, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Top drug company marketing executives suppressed a large European study suggesting their blockbuster medication Neurontin was ineffective for chronic nerve pain, and they privately strategized about how to silence a British researcher who wanted to go public with the data, according to newly filed documents and e-mails that are part of a Boston court case. (Full article: 1430 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass